0.00Open0.00Pre Close0 Volume0 Open Interest2.50Strike Price0.00Turnover1592.13%IV-14.09%PremiumJan 17, 2025Expiry Date0.41Intrinsic Value100Multiplier24DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9814Delta0.0038Gamma1.04Leverage Ratio-0.0119Theta0.0000Rho1.02Eff Leverage0.0003Vega
Kazia Therapeutics Stock Discussion
Kazia Therapeutics to Present Data Highlighting Synergistic Activity Between Paxalisib and Immunotherapy in Immunotherapy-Resistant Triple Negative Breast Cancer Model at the San Antonio Breast Cancer Symposium
Wednesday, 11th December at 8:00 am
SYDNEY, Dec. 11, 2024 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development, announced that data from two abstracts will be presented at the San Antonio Breast Cancer Symposium ...
📊⚡️📊
Larger Image: tradingview.com...
$Kazia Therapeutics (KZIA.US)$
📊⚡️📊
📊⚡️📊
No comment yet